BioSpace News Archive

Press Releases

Telo Genomics Expands its Strategic Collaboration with Mayo Clinic

October 30, 2024
·
6 min read
Press Releases

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

October 30, 2024
·
5 min read
Press Releases

Havah Therapeutics to Present Real World Data at the RiseUp for Breast Cancer Conference

October 30, 2024
·
1 min read
Press Releases

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics

October 30, 2024
·
4 min read
Press Releases

FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy

October 30, 2024
·
4 min read
Press Releases

ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development

October 30, 2024
·
3 min read
Press Releases

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

October 30, 2024
·
8 min read
Press Releases

Ajax Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of Myelofibrosis

October 30, 2024
·
3 min read
Press Releases

BridgeBio Oncology Therapeutics (BBOT) Announces First Patient Dosed with First-in-Class BBO-10203, a RAS:PI3Kα Breaker, in the Phase 1 BREAKER-101 Trial for Advanced Solid Tumors

October 30, 2024
·
3 min read
Press Releases

Incyte to Present at Upcoming Investor Conferences

October 30, 2024
·
1 min read